Ikeda Osamu, Sekine Yuichi, Mizushima Akihiro, Oritani Kenji, Yasui Teruhito, Fujimuro Masahiro, Muromoto Ryuta, Nanbo Asuka, Matsuda Tadashi
Department of Immunology, Graduate School of Pharmaceutical Sciences, Hokkaido University, Kita-Ku Kita 12 Nishi 6, Sapporo, Japan.
FEBS Lett. 2009 May 19;583(10):1567-74. doi: 10.1016/j.febslet.2009.04.022. Epub 2009 Apr 18.
Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) activates NF-kappaB signaling pathways through the two C-terminal regions, CTAR1 and CTAR2. BS69 has previously been shown to be involved in LMP1-induced c-Jun N-terminal kinase activation through CTAR2 by interacting with tumor necrosis factor (TNFR) receptor-associated factor 6. In the present study, our manipulation of BS69 expression clearly indicates that BS69 negatively regulates LMP1-mediated NF-kappaB activation and up-regulates IL-6 mRNA expression and IkappaB degradation. Our immunoprecipitation experiments suggest that BS69 decreases complex formation between LMP1 and TNFR-associated death domain protein (TRADD).
爱泼斯坦-巴尔病毒(EBV)潜伏膜蛋白1(LMP1)通过两个C末端区域CTAR1和CTAR2激活核因子κB信号通路。先前已表明,BS69通过与肿瘤坏死因子(TNFR)受体相关因子6相互作用,参与LMP1通过CTAR2诱导的c-Jun氨基末端激酶激活。在本研究中,我们对BS69表达的调控清楚地表明,BS69负向调节LMP1介导的核因子κB激活,并上调白细胞介素-6 mRNA表达和IκB降解。我们的免疫沉淀实验表明,BS69减少了LMP1与TNFR相关死亡结构域蛋白(TRADD)之间的复合物形成。